Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnieszka Onisko

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Entropy (Basel, Switzerland)|November 27, 2024
Sensitivity of Bayesian Networks to Noise in Their ParametersAgnieszka Onisko, Marek J Druzdzel
Journal of the American Society of Cytopathology|May 3, 2019
Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening ModelR Marshall Austin, Agnieszka Onisko
Entropy (Basel, Switzerland)|November 27, 2024
Sensitivity of Bayesian Networks to Errors in Their StructureAgnieszka Onisko, Marek J Druzdzel
American Journal of Clinical Pathology|August 24, 2018
Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV CotestingR Marshall Austin, Agnieszka Onisko, Chengquan Zhao
Journal of the American Society of Cytopathology|August 26, 2020
Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?R Marshall Austin, Agnieszka Onisko, Chengquan Zhao
American Journal of Clinical Pathology|August 20, 2017
Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou TestsJing Yu, Agnieszka Onisko, R Marshall Austin
Acta Cytologica|December 1, 2020
Personalized Medicine and Cervical Screening: Development of Individualized Quantitative Risk Assessments for Cervical Adenocarcinoma and Adenocarcinoma in situTerri E Jones, Agnieszka Onisko, R Marshall Austin
Journal of Pathology Informatics|February 7, 2017
How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modelingAgnieszka Onisko, Marek J Druzdzel, R Marshall Austin
Journal of Pathology Informatics|June 2, 2020
Individualized Bayesian Risk Assessment for Cervical Squamous NeoplasiaLama F Farchoukh, Agnieszka Onisko, R Marshall Austin
Archives of Pathology & Laboratory Medicine|May 6, 2010
The Pittsburgh Cervical Cancer Screening Model: a risk assessment toolR Marshall Austin, Agnieszka Onisko, Marek J Druzdzel
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Entropy (Basel, Switzerland)|November 27, 2024
Sensitivity of Bayesian Networks to Noise in Their ParametersAgnieszka Onisko, Marek J Druzdzel
Journal of the American Society of Cytopathology|May 3, 2019
Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening ModelR Marshall Austin, Agnieszka Onisko
Entropy (Basel, Switzerland)|November 27, 2024
Sensitivity of Bayesian Networks to Errors in Their StructureAgnieszka Onisko, Marek J Druzdzel
American Journal of Clinical Pathology|August 24, 2018
Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV CotestingR Marshall Austin, Agnieszka Onisko, Chengquan Zhao
Journal of the American Society of Cytopathology|August 26, 2020
Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?R Marshall Austin, Agnieszka Onisko, Chengquan Zhao
American Journal of Clinical Pathology|August 20, 2017
Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou TestsJing Yu, Agnieszka Onisko, R Marshall Austin
Acta Cytologica|December 1, 2020
Personalized Medicine and Cervical Screening: Development of Individualized Quantitative Risk Assessments for Cervical Adenocarcinoma and Adenocarcinoma in situTerri E Jones, Agnieszka Onisko, R Marshall Austin
Journal of Pathology Informatics|February 7, 2017
How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modelingAgnieszka Onisko, Marek J Druzdzel, R Marshall Austin
Journal of Pathology Informatics|June 2, 2020
Individualized Bayesian Risk Assessment for Cervical Squamous NeoplasiaLama F Farchoukh, Agnieszka Onisko, R Marshall Austin
Archives of Pathology & Laboratory Medicine|May 6, 2010
The Pittsburgh Cervical Cancer Screening Model: a risk assessment toolR Marshall Austin, Agnieszka Onisko, Marek J Druzdzel
Pageof 3